COVID-19 Retrospective Study of Chest CTs from China: What is the Re…

Adam Bernheim

CT Coronary Calcium Scoring, Hard Plaque and Soft Plaque Visualizati…

Scripps Health

M. Budoff

MR Quantification: Guideline Gaps

Piedmont's Marcus Heart Valve Center

Coronary CTA for Assessing CAD - Are We There Yet?

Matthew Budoff

Modern Management of the LSCA in TEVAR

UPMC

M. Farber

How Do I Reverse Coronary Plaque?

Scripps Health

C. J. Suhar

Patient Perspective: Cardiac Amyloidosis

Scripps Health

M. Nichols

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

Coronary Calcium Testing: Principles and Clinical Application

Right Care Initiative

A. Taylor

Peripheral Vein Cannulation Using Ultrasound: Should You Choose the …

Venous Edge

W. Marston, H. Gajraj

CVD Risk Assessment: Will CCTA with FFRCT and Plaque Analysis Change…

Society for Cardiovascular Angiography & Interventions (SCAI)

G. Fandetti, S. Rinehart

Cardiac Amyloidosis: An Overlooked but Treatable Cause of HFpEF

Inova Heart and Vascular Institute - Advanced Heart Failure Symposium

Case-Study: FFRCT & Disruptive Technology at My Facility

Society for Cardiovascular Angiography & Interventions (SCAI)

M. Rinaldi

Informed Cath Lab Planning & Treatment with the CCTA + FFRCT Pathway

Society for Cardiovascular Angiography & Interventions (SCAI)

O. Khalique

SOHO 2022: Amyloidosis - Update and How To Use Novel Agents

SOHO 2022 Tenth Annual Meeting

S. Lentzsch